SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-20-027151
Filing Date
2020-12-02
Accepted
2020-12-02 21:06:38
Documents
2
Period of Report
2020-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 15479
2 EXHIBIT 24 brhc10017541_ex24.htm EX-24 5797
  Complete submission text file 0001140361-20-027151.txt   22594
Mailing Address 3052 PACIFIC AVENUE SAN FRANCISCO CA 94115
Business Address
Tananbaum James B. (Reporting) CIK: 0001581754 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39743 | Film No.: 201365492

Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Issuer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations